Buyers in this market use the phrase FDA approved loosely, and the looseness costs clinics money. Devices are generally cleared or authorised for a specific intended use; some products are regulated as drugs or biologics; and the status always attaches to the product and its stated use rather than to whoever sells it. A supplier that describes itself as FDA approved is describing nothing checkable.

This guide explains what the different statuses actually mean, how a clinic can verify a claim, and what documentation to hold for equipment, instruments and consumables.

What This Equipment Category Covers

The category covers what a dermatology or aesthetic clinic buys to deliver treatment: energy-based devices, handpieces and delivery systems, single-use instruments and probes, disposables and general medical supplies, and the software that records their use.

Each of those sits under a different regulatory pathway. Energy-based devices are generally cleared or authorised by intended use. Single-use instruments and disposables may be registered devices. Certain injectable products are regulated as drugs or biologics rather than devices. Treating the whole supply list as one category is where verification goes wrong.

Technology Options Compared

For buying purposes the supply list divides by what has to be checked, not by what is being treated.

Two consequences follow. First, the question to ask is never whether a supplier is approved but which pathway each product sits under and what evidence exists for it. Second, a supplier that can answer that question per product is describing a compliance process; one that answers with a general assurance is describing a marketing position.

Specification Points That Decide the Buy

Four things decide whether a supply line is legitimate: the pathway the product sits under, the reference that evidences it, the labelling on the product itself, and the traceability from manufacturer to clinic.

Pathway follows from intended use, which the FDA explains in its guidance on determining whether a product is a medical device. The reference is the clearance or authorisation number where a device pathway applies. Labelling is what arrives on the product rather than in a brochure. Traceability is the invoice and lot chain that shows where the item came from.

Where a claim cannot be checked, treat it as absent rather than assume it. Checking a clearance takes minutes in the FDA 510(k) premarket notification database, and the establishment behind a listing can be confirmed in the registration and listing database.

New Versus Pre-Owned

New, certified refurbished and as-is equipment allocate risk differently, but regulatory status does not change with resale: it attaches to the model and its intended use. What changes on a pre-owned purchase is the documentation trail the clinic has to assemble.

For consumables and single-use items the position is stricter, because sterility and expiry are properties of the physical item rather than of the model. Where packaging is unmarked or the supplier cannot name the source, the item cannot be assessed and should not be used in patient care regardless of price.

Compare on total cost across the whole supply decision: the product, any documentation or translation required, freight and cold-chain where relevant, and the cost of holding adequate stock cover.

Service, Consumables and Downtime

Supply decisions carry running costs beyond the unit price. Ordering frequency, minimum order quantities, expiry windows and storage all affect what a supply line actually costs a clinic, and none of them appear on a price list.

Model supply in three parts. Consumption per procedure, so the order quantity reflects real use. Lead time and minimum order, because both determine the stock a clinic has to hold. And expiry or shelf life, because items bought in bulk can expire before they are used and that loss is a real cost.

Device service belongs in the same model. Published maintenance and device-safety guidance, such as that from ECRI, is a reasonable external check on realistic service intervals, and checking the model against the FDA recall and early alert listings belongs in the same routine.

On consumable supply, maintenance and documentation converge: lot and expiry records are what make a recall response possible, and they are generated at the point of ordering rather than at the point of an incident. A clinic that captures them on receipt, in the same file as the product reference and supplier, can answer a regulator or a manufacturer within minutes. One that reconstructs them afterwards usually cannot, and that gap is discovered at the least convenient moment.

Regulatory Position to Confirm

Regulatory position determines the requirements that apply to a product and the obligations that follow for the clinic. In the United States, laser and light-based products are subject to the federal performance standard for light-emitting products in addition to any device pathway, and the FDA’s overview of laser products and instruments explains how the labelling and reporting requirements interact.

Three practical rules apply to supply. Keep the clearance or conformity reference for each product line rather than for the supplier. Keep lot or batch traceability for consumables, because recall response depends on it. And keep the labelling and instructions for use in the language required in your market, since translation obligations sit with the supplier rather than the clinic.

Where a clinic advertises treatment outcomes or product claims, substantiation is expected; the FTC advertising guidance sets out what that involves.

How to Shortlist

Shortlist supply lines by asking what pathway each product sits under and what evidences it. A supplier that answers per product is easier to work with than one that answers per company.

Then apply four filters. Is the reference checkable in the public database? Does the label match the configuration being supplied? Is there lot traceability from manufacturer to clinic? And is the lead time short enough that the clinic is not holding excessive stock to cover uncertainty?

Finally, test the answers. Request a sample of the labelling before placing a first order, confirm the expiry profile of anything with limited shelf life, and verify one product line end to end before relying on the supplier across the whole list.

Three facts settle a supply decision: which pathway each product sits under, whether that can be checked independently, and whether the supplier can evidence the chain from manufacturer to clinic.